Affordable Healthcare for All: VMRC CEO Discusses the Benefits of Generic Drugs
CEO, VMRC & Strategic Board Advisor cum President, Global Critical Care, Saransh Chaudhary, recently published an article in The Times of India titled "Generics Hold the Key to Affordable Healthcare." In the article, he emphasized the importance of generic drugs in making healthcare more affordable and accessible to all.
Generics are often stigmatised as being lower in quality and less effective than their name brand equivalents, and as such when off-patent drugs become more affordable many patients still prefer to select the pricier option. In turn this takes away the incentive for companies selling generics, which is why it is so vital that awareness is raised surrounding their efficacy and reliablity. This can only be achieved by strengthening regulations surrounding quality checks, thereby giving both patients and doctors confidence that generic alternatives are a viable choice.
Mr. Chaudhary stated that generic drugs are the exact copies of branded drugs, but at a fraction of the cost. He also highlighted the need for more awareness and acceptance of generic drugs among healthcare professionals and patients. He emphasized that generic drugs are not inferior in quality or efficacy, and are subject to the same rigorous testing and quality checks as branded drugs.
Mr. Chaudhary further stated that the government's push for the use of generic drugs through various policies and initiatives is a step in the right direction towards achieving affordable healthcare for all. He also called for more investment in research and development of generic drugs to drive innovation and make them more accessible to patients.
In conclusion, Mr. Chaudhary emphasized that the use of generic drugs can significantly reduce the cost of healthcare and improve access to life-saving drugs for all sections of society. He urged all stakeholders in the healthcare industry to work together towards making generic drugs more widely accepted and accessible.
